$PBH
Prestige Consumer Healthcare Inc Stock $pbh

$pbh Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000129594717000024 Filed on August 03, 2017

Income Statement

Concept	2017 Q2	2016 Q2
Revenue	$256.6M	$209.6M
YoY Change	22.43%	9.08%
Cost Of Revenue	$113.1M	$87.98M
YoY Change	28.54%	10.12%
Gross Profit	$143.5M	$121.6M
YoY Change	18.0%	8.34%
Gross Profit Margin	55.92%	58.02%
Selling, General & Admin	$57.30M	$47.10M
YoY Change	21.66%	7.05%
% of Gross Profit	39.94%	38.74%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$8.507M	$6.832M
YoY Change	24.52%	19.44%
% of Gross Profit	5.93%	5.62%
Operating Expenses	$64.52M	$109.4M
YoY Change	-41.01%	119.94%
Operating Profit	$78.96M	$12.21M
YoY Change	546.43%	-80.46%
Interest Expense	-$26.30M	-$21.10M
YoY Change	24.64%	-3.65%
% of Operating Profit	-33.31%	-172.75%
Other Income/Expense, Net	$74.00K
YoY Change
Pretax Income	$52.69M	-$8.913M
YoY Change	-691.14%	-122.19%
Income Tax	$18.93M	-$3.382M
% Of Pretax Income	35.93%
Net Earnings	$33.76M	-$5.531M
YoY Change	-710.36%	-121.13%
Net Earnings / Revenue	13.16%	-2.64%
Basic Earnings Per Share	$0.64	-$0.10
Diluted Earnings Per Share	$0.63	-$0.10
COMMON SHARES
Basic Shares Outstanding	53.04M shares	52.88M shares
Diluted Shares Outstanding	53.51M shares	52.88M shares

Balance Sheet

Concept	2017 Q2	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$44.10M	$28.90M
YoY Change	52.6%	33.8%
Cash & Equivalents	$44.14M	$28.88M
Short-Term Investments
Other Short-Term Assets	$30.70M	$71.10M
YoY Change	-56.82%	259.09%
Inventory	$118.7M	$92.87M
Prepaid Expenses
Receivables	$134.7M	$88.44M
Other Receivables	$0.00	$1.000M
Total Short-Term Assets	$328.2M	$281.4M
YoY Change	16.66%	39.94%
LONG-TERM ASSETS
Property, Plant & Equipment	$50.47M	$15.08M
YoY Change	234.68%	14.64%
Goodwill	$615.5M	$356.5M
YoY Change	72.62%	22.57%
Intangibles	$2.898B	$2.224B
YoY Change	30.34%	4.4%
Long-Term Investments
YoY Change
Other Assets	$7.143M	$1.918M
YoY Change	272.42%	22.79%
Total Long-Term Assets	$3.571B	$2.597B
YoY Change	37.51%	6.64%
TOTAL ASSETS
Total Short-Term Assets	$328.2M	$281.4M
Total Long-Term Assets	$3.571B	$2.597B
Total Assets	$3.900B	$2.878B
YoY Change	35.47%	9.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$62.74M	$35.01M
YoY Change	79.19%	-25.77%
Accrued Expenses	$71.80M	$55.50M
YoY Change	29.37%	26.42%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$153.6M	$100.1M
YoY Change	53.4%	-1.62%
LONG-TERM LIABILITIES
Long-Term Debt	$2.145B	$1.577B
YoY Change	36.01%	4.7%
Other Long-Term Liabilities	$17.44M	$2.847M
YoY Change	512.68%	13.11%
Total Long-Term Liabilities	$2.163B	$1.580B
YoY Change	36.87%	4.72%
TOTAL LIABILITIES
Total Short-Term Liabilities	$153.6M	$100.1M
Total Long-Term Liabilities	$2.163B	$1.580B
Total Liabilities	$3.041B	$2.141B
YoY Change	42.04%	8.47%
SHAREHOLDERS EQUITY
Retained Earnings	$430.5M	$321.8M
YoY Change	33.78%	26.9%
Common Stock	$533.0K	$532.0K
YoY Change	0.19%	0.38%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$7.621M	$6.558M
YoY Change	16.21%	28.06%
Treasury Stock Shares	352.0K shares	331.0K shares
Shareholders Equity	$858.5M	$737.5M
YoY Change
Total Liabilities & Shareholders Equity	$3.900B	$2.878B
YoY Change	35.47%	9.18%

Cashflow Statement

Concept	2017 Q2	2016 Q2
OPERATING ACTIVITIES
Net Income	$33.76M	-$5.531M
YoY Change	-710.36%	-121.13%
Depreciation, Depletion And Amortization	$8.507M	$6.832M
YoY Change	24.52%	19.44%
Cash From Operating Activities	$54.12M	$51.30M
YoY Change	5.5%	17.88%
INVESTING ACTIVITIES
Capital Expenditures	$2.554M	$895.0K
YoY Change	185.36%	14.74%
Acquisitions
YoY Change
Other Investing Activities	$1.000M	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$1.584M	-$895.0K
YoY Change	76.98%	105.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$50.59M	-$48.00M
YoY Change	5.41%	11.92%
NET CHANGE
Cash From Operating Activities	$54.12M	$51.30M
Cash From Investing Activities	-$1.584M	-$895.0K
Cash From Financing Activities	-$50.59M	-$48.00M
Net Change In Cash	$1.943M	$2.407M
YoY Change	-19.28%	1115.66%
FREE CASH FLOW
Cash From Operating Activities	$54.12M	$51.30M
Capital Expenditures	$2.554M	$895.0K
Free Cash Flow	$51.57M	$50.41M
YoY Change	2.3%	17.93%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q2	dei	Amendment Flag AmendmentFlag	false
CY2017Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2017Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2017Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2017Q2	dei	Document Period End Date DocumentPeriodEndDate	2017-06-30
CY2017Q2	dei	Document Type DocumentType	10-Q
CY2017Q2	dei	Entity Central Index Key EntityCentralIndexKey	0001295947
CY2017Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	53000170	shares
CY2017Q2	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2017Q2	dei	Entity Registrant Name EntityRegistrantName	Prestige Brands Holdings, Inc.
CY2017Q1	pbh	Accrued And Other Liabilities Current AccruedAndOtherLiabilitiesCurrent	83661000	USD
CY2017Q2	pbh	Accrued And Other Liabilities Current AccruedAndOtherLiabilitiesCurrent	82465000	USD
CY2017Q1	pbh	Accrued Lease Termination Costs Current AccruedLeaseTerminationCostsCurrent	843000	USD
CY2017Q2	pbh	Accrued Lease Termination Costs Current AccruedLeaseTerminationCostsCurrent	730000	USD
CY2017Q1	pbh	Accrued Production Costs Current AccruedProductionCostsCurrent	4580000	USD
CY2017Q2	pbh	Accrued Production Costs Current AccruedProductionCostsCurrent	6883000	USD
CY2016Q2	pbh	Contribution Margin ContributionMargin	93956000	USD
CY2017Q2	pbh	Contribution Margin ContributionMargin	106532000	USD
CY2016Q2	pbh	Cost Of Sales Exclusive Of Depreciation CostOfSalesExclusiveOfDepreciation	87984000	USD
CY2017Q2	pbh	Cost Of Sales Exclusive Of Depreciation CostOfSalesExclusiveOfDepreciation	111757000	USD
CY2017Q1	pbh	Intercompany Receivable IntercompanyReceivable	0	USD
CY2016Q2	pbh	Effective Income Tax Rate Reconciliation Sharebased Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationSharebasedCompensationExcessTaxBenefitAmount	1400000	USD
CY2017Q2	pbh	Effective Income Tax Rate Reconciliation Sharebased Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationSharebasedCompensationExcessTaxBenefitAmount	900000	USD
CY2016Q2	pbh	Equity In Income Of Subsidiaries EquityInIncomeOfSubsidiaries	0	USD
CY2017Q2	pbh	Equity In Income Of Subsidiaries EquityInIncomeOfSubsidiaries	0	USD
CY2017Q2	pbh	Finite Lived Intangible Assets Accumulated Amortization Translation Adjustments FiniteLivedIntangibleAssetsAccumulatedAmortizationTranslationAdjustments	6000	USD
CY2016Q2	pbh	General And Administrative And Depreciation And Amortization Expense GeneralAndAdministrativeAndDepreciationAndAmortizationExpense	81742000	USD
CY2017Q2	pbh	General And Administrative And Depreciation And Amortization Expense GeneralAndAdministrativeAndDepreciationAndAmortizationExpense	27503000	USD
CY2016Q2	pbh	Increase Decrease In Intercompany Activity Financing Activities Net IncreaseDecreaseInIntercompanyActivityFinancingActivitiesNet	0	USD
CY2017Q2	pbh	Increase Decrease In Intercompany Activity Financing Activities Net IncreaseDecreaseInIntercompanyActivityFinancingActivitiesNet	0	USD
CY2017Q1	pbh	Intangible Assets Gross IntangibleAssetsGross	3030956000	USD
CY2017Q2	pbh	Intangible Assets Gross IntangibleAssetsGross	3031476000	USD
CY2017Q2	pbh	Intangible Assets Translation Adjustments IntangibleAssetsTranslationAdjustments	520000	USD
CY2017Q1	pbh	Intercompany Payable IntercompanyPayable	0	USD
CY2017Q2	pbh	Intercompany Payable IntercompanyPayable	0	USD
CY2017Q2	pbh	Intercompany Receivable IntercompanyReceivable	0	USD
CY2017Q1	pbh	Investment In Subsidiary InvestmentInSubsidiary	0	USD
CY2017Q2	pbh	Investment In Subsidiary InvestmentInSubsidiary	0	USD
CY2017Q1	pbh	Long Term Debt Excluding Current Maturities Gross LongTermDebtExcludingCurrentMaturitiesGross	2222000000	USD
CY2017Q2	pbh	Long Term Debt Excluding Current Maturities Gross LongTermDebtExcludingCurrentMaturitiesGross	2172000000	USD
CY2017Q1	pbh	Long Term Debt Gross Current Maturities LongTermDebtGrossCurrentMaturities	0	USD
CY2017Q2	pbh	Long Term Debt Gross Current Maturities LongTermDebtGrossCurrentMaturities	0	USD
CY2016Q2	pbh	Number Of Third Party Manufacturers NumberOfThirdPartyManufacturers	102	manufacturer
CY2017Q2	pbh	Number Of Third Party Manufacturers NumberOfThirdPartyManufacturers	116	manufacturer
CY2016Q2	pbh	Share Based Compensation Arrangement By Share Based Payment Award Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue	7000000	USD
CY2017Q2	pbh	Share Based Compensation Arrangement By Share Based Payment Award Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedInPeriodTotalFairValue	4900000	USD
CY2014Q2	pbh	Sharebased Compensation Arrangementby Sharebased Payment Award Extensionof Expiration Period SharebasedCompensationArrangementbySharebasedPaymentAwardExtensionofExpirationPeriod	P10Y
CY2016Q2	pbh	Total Other Income Expense TotalOtherIncomeExpense	-21127000	USD
CY2017Q2	pbh	Total Other Income Expense TotalOtherIncomeExpense	-26341000	USD
CY2017Q2	pbh	Voting Rights Number Of Votes Per Common Share Owned VotingRightsNumberOfVotesPerCommonShareOwned	1	vote
CY2017Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	70218000	USD
CY2017Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	62738000	USD
CY2017Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	136742000	USD
CY2017Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	134725000	USD
CY2017Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	3840000	USD
CY2017Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	38000	USD
CY2017Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	29384000	USD
CY2017Q2	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	35284000	USD
CY2017Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2412000	USD
CY2017Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2168000	USD
CY2017Q1	us-gaap	Accrued Rent Current AccruedRentCurrent	492000	USD
CY2017Q2	us-gaap	Accrued Rent Current AccruedRentCurrent	482000	USD
CY2017Q1	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	1782000	USD
CY2017Q2	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	1096000	USD
CY2017Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	460401000	USD
CY2016Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1900000	USD
CY2017Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-26352000	USD
CY2017Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-25232000	USD
CY2017Q2	us-gaap	Common Stock Value CommonStockValue	533000	USD
CY2017Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	458255000	USD
CY2016Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11355000	USD
CY2017Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	34879000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44135000	USD
CY2016Q2	us-gaap	Cost Of Revenue CostOfRevenue	87984000	USD
CY2017Q2	us-gaap	Cost Of Revenue CostOfRevenue	113097000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1647000	USD
CY2017Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2017Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	53287000	shares
CY2017Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	53352000	shares
CY2017Q1	us-gaap	Common Stock Value CommonStockValue	533000	USD
CY2017Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1700000	USD
CY2017Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	13010000	USD
CY2017Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	13556000	USD
CY2016Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2231000	USD
CY2017Q2	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1746000	USD
CY2017Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5854000	USD
CY2017Q1	us-gaap	Assets Assets	3911348000	USD
CY2017Q2	us-gaap	Assets Assets	3899561000	USD
CY2017Q1	us-gaap	Assets Current AssetsCurrent	334434000	USD
CY2017Q2	us-gaap	Assets Current AssetsCurrent	328225000	USD
CY2017Q1	us-gaap	Business Combination Separately Recognized Transactions Liabilities Recognized BusinessCombinationSeparatelyRecognizedTransactionsLiabilitiesRecognized	19000000	USD
CY2017Q2	us-gaap	Business Combination Separately Recognized Transactions Liabilities Recognized BusinessCombinationSeparatelyRecognizedTransactionsLiabilitiesRecognized	19000000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27230000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28877000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	41855000	USD
CY2017Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	2280000	USD
CY2017Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2016Q2	us-gaap	Cost Of Services Depreciation And Amortization CostOfServicesDepreciationAndAmortization	0	USD
CY2017Q2	us-gaap	Cost Of Services Depreciation And Amortization CostOfServicesDepreciationAndAmortization	1340000	USD
CY2017Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2222000000	USD
CY2017Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2172000000	USD
CY2017Q1	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	28268000	USD
CY2017Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	26591000	USD
CY2016Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-9660000	USD
CY2017Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	9225000	USD
CY2017Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	715086000	USD
CY2017Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	724545000	USD
CY2017Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	715086000	USD
CY2017Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	724545000	USD
CY2017	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2017Q2	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	0	USD
CY2016Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3401000	USD
CY2016Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6832000	USD
CY2017Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	8507000	USD
CY2016Q2	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-55453000	USD
CY2017Q2	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	0	USD
CY2017Q2	us-gaap	Dividends Common Stock DividendsCommonStock	0	USD
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.64
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.63
CY2016Q2	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-760000	USD
CY2017Q2	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	337000	USD
CY2016Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.379
CY2017Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.359
CY2017Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	15535000	USD
CY2017Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8973000	USD
CY2017Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	12800000	USD
CY2017Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P12M0D
CY2016Q2	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	700000	USD
CY2017Q2	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	500000	USD
CY2016Q2	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	-550000	USD
CY2017Q2	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	-302000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	127343000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	133203000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	314458000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	308658000	USD
CY2016Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2017Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-490000	USD
CY2016Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19457000	USD
CY2017Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20336000	USD
CY2017Q1	us-gaap	Goodwill Goodwill	615252000	USD
CY2017Q2	us-gaap	Goodwill Goodwill	615451000	USD
CY2017Q2	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	199000	USD
CY2016Q2	us-gaap	Gross Profit GrossProfit	121591000	USD
CY2017Q2	us-gaap	Gross Profit GrossProfit	143476000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8913000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	52688000	USD
CY2016Q2	us-gaap	Income Loss From Subsidiaries Before Tax IncomeLossFromSubsidiariesBeforeTax	0	USD
CY2017Q2	us-gaap	Income Loss From Subsidiaries Before Tax IncomeLossFromSubsidiariesBeforeTax	0	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3382000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18929000	USD
CY2016Q2	us-gaap	Income Taxes Paid IncomeTaxesPaid	1357000	USD
CY2017Q2	us-gaap	Income Taxes Paid IncomeTaxesPaid	2230000	USD
CY2016Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-3634000	USD
CY2017Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-8024000	USD
CY2016Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5151000	USD
CY2017Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1543000	USD
CY2017Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1558000	USD
CY2016Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4327000	USD
CY2017Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2899000	USD
CY2016Q2	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	0	USD
CY2017Q2	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	287000	USD
CY2016Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-5697000	USD
CY2017Q2	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-9604000	USD
CY2016Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2017Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	471000	shares
CY2017Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2589155000	USD
CY2017Q2	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	2589615000	USD
CY2017Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2903613000	USD
CY2017Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2898273000	USD
CY2017Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	3518865000	USD
CY2017Q2	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	3513724000	USD
CY2017Q1	us-gaap	Interest And Dividends Payable Current InterestAndDividendsPayableCurrent	8130000	USD
CY2017Q2	us-gaap	Interest And Dividends Payable Current InterestAndDividendsPayableCurrent	8414000	USD
CY2016Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	21184000	USD
CY2017Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	26410000	USD
CY2016Q2	us-gaap	Interest Paid InterestPaid	18337000	USD
CY2017Q2	us-gaap	Interest Paid InterestPaid	24298000	USD
CY2017Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	105256000	USD
CY2017Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	105454000	USD
CY2017Q1	us-gaap	Inventory Net InventoryNet	115609000	USD
CY2017Q2	us-gaap	Inventory Net InventoryNet	118707000	USD
CY2017Q1	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	9984000	USD
CY2017Q2	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	12887000	USD
CY2017Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	6600000	USD
CY2017Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	4900000	USD
CY2017Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	369000	USD
CY2017Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	366000	USD
CY2016Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	57000	USD
CY2017Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	69000	USD
CY2017Q1	us-gaap	Liabilities Liabilities	3088799000	USD
CY2017Q2	us-gaap	Liabilities Liabilities	3041014000	USD
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3911348000	USD
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3899561000	USD
CY2017Q1	us-gaap	Liabilities Current LiabilitiesCurrent	162009000	USD
CY2017Q2	us-gaap	Liabilities Current LiabilitiesCurrent	153617000	USD
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	1682000000	USD
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	490000000	USD
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2017Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	USD
CY2017Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2193732000	USD
CY2017Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2145409000	USD
CY2016Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	27635000	USD
CY2017Q2	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	36944000	USD
CY2017Q2	us-gaap	Minority Interest Ownership Percentage By Parent MinorityInterestOwnershipPercentageByParent	1
CY2016Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-47999000	USD
CY2017Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-50594000	USD
CY2016Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-895000	USD
CY2017Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1584000	USD
CY2016Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	51301000	USD
CY2017Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	54121000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-5531000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	33759000	USD
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	109377000	USD
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	64447000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	12214000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	79029000	USD
CY2017Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5793000	USD
CY2017Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	7811000	USD
CY2017Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7454000	USD
CY2017Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7143000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	0	USD
CY2017Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-1000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-5824000	USD
CY2017Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1120000	USD
CY2016Q2	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	6832000	USD
CY2017Q2	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	7167000	USD
CY2017Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	17972000	USD
CY2017Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	17443000	USD
CY2016Q2	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	805000	USD
CY2017Q2	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	86000	USD
CY2016Q2	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	9000	USD
CY2017Q2	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2016Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1395000	USD
CY2017Q2	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1027000	USD
CY2016Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	895000	USD
CY2017Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2554000	USD
CY2017Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2017Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2017Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1940000	USD
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	32.64
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	224800	shares
CY2017Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1713000	USD
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee	2500000.0	shares
CY2017Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	40228000	USD
CY2017Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	30658000	USD
CY2016Q2	us-gaap	Proceeds From Previous Acquisition ProceedsFromPreviousAcquisition	0	USD
CY2017Q2	us-gaap	Proceeds From Previous Acquisition ProceedsFromPreviousAcquisition	970000	USD
CY2016Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3400000	USD
CY2016Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3405000	USD
CY2017Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	433000	USD
CY2017Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	400000	USD
CY2017Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	50595000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	50469000	USD
CY2017	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	0	USD
CY2017Q2	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	0	USD
CY2016Q2	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	50000000	USD
CY2017Q2	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	50000000	USD
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	396707000	USD
CY2017Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	430466000	USD
CY2016Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	208770000	USD
CY2017Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	256487000	USD
CY2016Q2	us-gaap	Sales Revenue Net SalesRevenueNet	209575000	USD
CY2017Q2	us-gaap	Sales Revenue Net SalesRevenueNet	256573000	USD
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee	1000000.0	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	2200000	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	386400	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	527300	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	25.20
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	31.95
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	300000	USD
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	45500	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	5800	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	37.34
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	182800	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	22.26
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	21.20
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	14700000	USD
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	12123000	USD
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	727700	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	801300	shares
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	772300	shares
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	935500	shares
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	30.70
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	37.55
CY2017Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	37.70
CY2017Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	41.42
CY2016Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	32.20
CY2017Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	31.35
CY2016Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	57.18
CY2017Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	56.11
CY2016Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	11669000	USD
CY2017Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	11305000	USD
CY2016Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y8M12D
CY2017Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y5M18D
CY2016Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y
CY2017Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y7M30D
CY2016Q2	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	10500000	USD
CY2017Q2	us-gaap	Shipping Handling And Transportation Costs ShippingHandlingAndTransportationCosts	13500000	USD
CY2016Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	105700	shares
CY2017Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	13800	shares
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	822549000	USD
CY2017Q2	us-gaap	Stockholders Equity StockholdersEquity	858547000	USD
CY2016Q2	us-gaap	Translation Adjustment Functional To Reporting Currency Net Of Tax Period Increase Decrease TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease	-5824000	USD
CY2017Q2	us-gaap	Translation Adjustment Functional To Reporting Currency Net Of Tax Period Increase Decrease TranslationAdjustmentFunctionalToReportingCurrencyNetOfTaxPeriodIncreaseDecrease	1119000	USD
CY2017Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	332000	shares
CY2017Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	352000	shares
CY2017Q1	us-gaap	Treasury Stock Value TreasuryStockValue	6594000	USD
CY2017Q2	us-gaap	Treasury Stock Value TreasuryStockValue	7621000	USD
CY2017Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4100000	USD
CY2017Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3700000	USD
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52881000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53509000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52881000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53038000	shares
CY2017Q2	us-gaap	Advertising Cost Policy Expensed Advertising Cost AdvertisingCostPolicyExpensedAdvertisingCost	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;text-align:left;vertical-align:bottom;">Advertising and Promotion Costs</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Advertising and promotion costs are expensed as incurred.  Allowances for distribution costs associated with products, including slotting fees, are recognized as a reduction of sales.  Under these slotting fee distribution arrangements, the retailers allow our products to be placed on the stores' shelves in exchange for such fees.</font></div></div>
CY2017Q2	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Reclassification</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In accordance with Accounting Standards Update (“ASU”) 2016-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation - Stock Compensation (Topic 718)</font><font style="font-family:inherit;font-size:10pt;">, we have reclassified cash flows on our Condensed Consolidated Statements of Cash Flows related to excess tax benefits from a financing activity to an operating activity for all periods presented.</font></div></div>
CY2017Q2	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period.  Although these estimates are based on our knowledge of current events and actions that we may undertake in the future, actual results could differ from those estimates.  As discussed below, our most significant estimates include those made in connection with the valuation of intangible assets, stock-based compensation, fair value of debt, sales returns and allowances, trade promotional allowances, inventory obsolescence, the calculation of pension expense in our defined benefit plans, and the recognition of income taxes using an estimated annual effective tax rate.</font></div></div>

Files In Submission

Name	View Source	Status
0001295947-17-000024-index-headers.html	Edgar Link	pending
0001295947-17-000024-index.html	Edgar Link	pending
0001295947-17-000024.txt	Edgar Link	pending
0001295947-17-000024-xbrl.zip	Edgar Link	pending
exhibit3112017-06x30.htm	Edgar Link	pending
exhibit3122017-06x30.htm	Edgar Link	pending
exhibit3212017-06x30.htm	Edgar Link	pending
exhibit3222017-06x30.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
pbh-20170630.xml	Edgar Link	completed
pbh-20170630.xsd	Edgar Link	pending
pbh-20170630_cal.xml	Edgar Link	unprocessable
pbh-20170630_def.xml	Edgar Link	unprocessable
pbh-20170630_lab.xml	Edgar Link	unprocessable
pbh-20170630_pre.xml	Edgar Link	unprocessable
pbh10qjune302017.htm	Edgar Link	pending
pbhlogoa011a01a02a01a06.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PBH
Prestige Consumer Healthcare Inc Stock $pbh

2017 Q2 Form 10-Q Financial Statement

#000129594717000024 Filed on August 03, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PBH Prestige Consumer Healthcare Inc Stock $pbh

2017 Q2 Form 10-Q Financial Statement

#000129594717000024 Filed on August 03, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PBH
Prestige Consumer Healthcare Inc Stock $pbh